Press Release | December 29, 2020 | BIO Statements, Patient Advocacy, Cost & Value of Biopharmaceuticals, Drug Pricing Blue Print, Out-Of-Pocket Costs, Foreign Drug Importation
A judge in the United States District Court for the Northern District of California yesterday issued a preliminary injunction blocking the Administration’s “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B providers.
The issuance comes weeks after the…